Athenahealth (ATHN) Could Fall Back to $110-$120 Range - RBC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Pre-Open Movers 09/18: (VKTX) (NXEO) (TLRY) Higher; (MDGL) (ATHN) (CBRL) Lower (more...)
September 18, 2018 9:24 AM EDTToday's Pre-Open Movers
Viking Therapeutics, Inc. (NASDAQ: VKTX) 120.7% HIGHER; announced positive top-line results from a 12-week Phase 2 study of VK2809, its novel liver-selective thyroid receptor beta agonist, in patients with non-alcoholic fatty liver disease (NAFLD) and elevated low-density lipoprotein cholesterol (LDL-C). The study successfully achieved its primary endpoint, with patients receiving VK2809 demonstrating statistically... More
Options expected to have increasing volume: ATHN FDX ORCL MU
September 18, 2018 8:36 AM EDTOptions expected to have increasing volume: ATHN FDX ORCL MU
... MoreElliott Said to Back Away from $160 per Share Bid for Athenahealth (ATHN) - NYP
September 18, 2018 6:26 AM EDTElliott Management has backed away from its $160 per share bid for Athenahealth (NASDAQ: ATHN), according to the New York Post. It could be considering a lower price.
... More


